PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Net Income towards Common Stockholders (2020 - 2025)

PRF Technologies' (PRFX) quarterly Net Income towards Common Stockholders came in at $6000.0 in Q2 2025, down 93.88% on a YoY basis from $98000.0 in Q2 2024, and down 93.88% quarter-over-quarter from $98000.0 in Q2 2024.

Analysis

PRF Technologies (PRFX) Net Income towards Common Stockholders (2020 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Net Income towards Common Stockholders for 6 consecutive years, with $6000.0 the latest figure, recorded in Q2 2025.

  • For the quarter ending Q2 2025, Net Income towards Common Stockholders fell 93.88% year-over-year to $6000.0; the trailing twelve-month figure through Jun 2025 stood at -$9.0 million (up 13.08% YoY), and the FY2025 full-year result was -$5.0 million, up 65.65% from the prior year.
  • Net Income towards Common Stockholders retreated to $6000.0 in Q2 2025 per PRFX's latest filing, from $98000.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $98000.0 in Q2 2024 and bottomed at -$5.6 million in Q1 2024.
  • Historically, Net Income towards Common Stockholders has averaged -$2.1 million across 5 years, with a median of -$1.8 million in 2022.
  • The sharpest annual moves came in 2021 and 2024: Net Income towards Common Stockholders sank 152.57% in 2021, then jumped 104.35% in 2024.
  • Over 5 years, Net Income towards Common Stockholders stood at -$1.7 million in 2021, then plunged by 87.02% to -$3.3 million in 2022, then dropped by 9.46% to -$3.6 million in 2023, then surged by 102.75% to $98000.0 in 2024, then tumbled by 93.88% to $6000.0 in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $6000.0, $98000.0, and -$5.6 million for Q2 2025, Q2 2024, and Q1 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn -576.00 Mn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn -118.80 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 46.85 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 69.61 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 260.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 24.70 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn -66.70 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 30.35 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 1.97 Mn
10 PRF Technologies 622,054.07 -10.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 6,000.00
Jun 30, 2024 98,000.00
Mar 31, 2024 -5.57 Mn
Dec 31, 2023 -3.56 Mn
Sep 30, 2023 -1.35 Mn
Jun 30, 2023 -2.25 Mn
Mar 31, 2023 -2.42 Mn
Dec 31, 2022 -3.26 Mn
Sep 30, 2022 -2.10 Mn
Jun 30, 2022 -1.85 Mn
Mar 31, 2022 -1.67 Mn
Dec 31, 2021 -1.74 Mn
Sep 30, 2021 -1.77 Mn
Jun 30, 2021 -1.66 Mn
Mar 31, 2021 -2.04 Mn
Dec 31, 2020 -691,000.00
Sep 30, 2020 -700,000.00
Jun 30, 2020 -969,000.00
Mar 31, 2020 -1.59 Mn
API Access

PRF Technologies Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PRFX&period=max&api_key=YOUR_API_KEY